Shares of a company engaged in the manufacture and sales of pharma intermediated and bulk drugs are in focus during the trading session of Tuesday, after reporting Q3 FY25 financial results with a rise in net pr of around 25 percent QoQ and 421 percent YoY.  With a market cap of Rs. 79.24 crores, the … Continue reading Pharma stock under ₹100 in focus after reporting 421% YoY increase in net profits